C3.ai vs Harte Hanks
AI and HHS side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AI and HHS compare
C3.ai is the larger company, worth 64 times as much as Harte Hanks ($1.9B against $29.9M).
Harte Hanks grew revenue faster over the last twelve months (−7.3% versus −37.5% for C3.ai).
Harte Hanks keeps more of each dollar of sales as profit, with a net margin of −3.2% compared with −192% at C3.ai.
C3.ai scores higher on the StockData Score (6 against 3 for Harte Hanks), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AI | HHS |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $29.9M |
| Share price | $11.82 | $4.01 |
| Change, 1 year | −20.3% | 37.3% |
| Change, 5 years | −70.4% | −52.1% |
| Beta (5Y) | 2.36 | 0.71 |
| Employees | 764 | 1,719 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.2× | 0.2× (better) |
| P/B | 2.7× | 2.1× (better) |
| FCF yield | −8.2% (better) | −32.4% |
| Fair value | $10.24 | – |
| Margin of safety | −15.5% | – |
| Growth | ||
| Revenue growth (TTM) | −37.5% | −7.3% (better) |
| Revenue growth, 5Y average | 6.4% (better) | −2.0% |
| Profitability | ||
| Gross margin | 29.1% | – |
| Operating margin | −203% | −4.6% (better) |
| Net margin | −192% | −3.2% (better) |
| FCF margin | −67.0% | −6.3% (better) |
| Return on equity | −59.8% | −29.0% (better) |
| Return on invested capital | −570% | −35.9% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.45 (better) |
| Current ratio | 6.16 (better) | 1.23 |
| Altman Z-score | 2.60 | 14.66 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 60.4% | 29.1% |
| Held by insiders | 19.2% | 39.8% |
| Insider net buying, 12 months | −$72.0M | – |
| Short interest, % of float | 32.4% | 0.98% |
Go deeper
- AI stock overview
- AI income statement
- AI valuation and score
- HHS stock overview
- HHS income statement
- HHS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.